Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $600 to $485.
Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.